Caring for the Ages
December 31, 2024
Showing 151 - 160 of 2397 results
Podcast
April 27, 2023
JAMDA On-The-Go | April 2023 | Insights into Infection Control, Oral Health, Antipsychotic Use, and Virtual Reality for Older Adults
Podcast
October 8, 2021
AOTG | Another Reflection on Antipsychotic Use in PALTC
Podcast
March 8, 2021
AMDA On-The-Go | Appropriate Use of Antipsychotic Medication in LTC
Podcast
April 29, 2019
AMDA On-The-Go | Appropriate Use of Antipsychotics in LTC Facilities
JAMDA
July 31, 2015
Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis
To establish the mortality risk and adverse events associated with the use of atypical antipsychotic medications in people with Parkinson disease psychosis (PDP) in a clinically defined trial cohort.
JAMDA
February 26, 2019
Antipsychotic Treatment Associated With Increased Mortality Risk in Patients With Dementia. A Registry-Based Observational Cohort Study
To assess all-cause mortality patients with dementia treated with typical and atypical antipsychotic drugs (APDs).
JAMDA
April 18, 2017
Antipsychotics and the Risk of Cerebrovascular Accident: A Systematic Review and Meta-Analysis of Observational Studies
Studies investigating the association between antipsychotic use and the risk of cerebrovascular accident (CVA) showed inconsistent results.
JAMDA
December 15, 2014
A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD)
Neuropsychiatric symptoms in Alzheimer disease (AD) cause significant distress and present a complex clinical challenge for treatment. Pharmacological treatment options are limited to antipsychotics, which carry extensive safety issues. There is emerging evidence to support the potential benefits of memant...
JAMDA
August 30, 2017